U.S. Online Retail and Ecommerce Stock News

NYSE:TMO
NYSE:TMOLife Sciences

Thermo Fisher Resets Footprint With Franklin Closure And US$9b Clario Deal

Thermo Fisher Scientific (NYSE:TMO) is closing its Franklin, Massachusetts facility and winding down operations, with significant job reductions as part of a broader restructuring. The company has agreed to acquire clinical trial and digital data specialist Clario for about $9 billion in cash. These moves reshape Thermo Fisher’s operational footprint and expand its reach in clinical research and digital health solutions. For investors watching NYSE:TMO, these announcements come at a time of...
NYSE:NOC
NYSE:NOCAerospace & Defense

Assessing Northrop Grumman (NOC) Valuation After Earnings Strength And New Defense Contract Wins

Northrop Grumman (NOC) is back in focus after reporting full year 2025 earnings, with revenue of US$41.954b and net income of US$4.182b, along with new defense contract wins in microelectronics and threat training systems. See our latest analysis for Northrop Grumman. The earnings release and fresh contracts in microelectronics and threat training systems come after a strong run in the shares, with a 30 day share price return of 14.1% and a 1 year total shareholder return of 51.9%, which...
NasdaqGM:GCT
NasdaqGM:GCTRetail Distributors

Assessing GigaCloud Technology (GCT) Valuation After Strong Multi Year Returns And Mixed Near Term Performance

Why GigaCloud Technology (GCT) is on investors’ radar today GigaCloud Technology (GCT) has drawn attention after recent trading, with the stock last closing at $38.57 and showing mixed short term performance, including a 1 day decline and a weaker past month. For context, the shares show a negative past week return and a negative month move, set against a positive past 3 months and a strong 1 year total return. That blend of shorter term softness and longer term strength is where many...
NasdaqCM:NAGE
NasdaqCM:NAGEPersonal Products

A Look At Niagen Bioscience (NAGE) Valuation As New Partner Launches And Clinical Data Gain Attention

Recent coverage around Niagen Bioscience (NAGE) has focused on upcoming launches with major consumer product partners and fresh clinical data tied to its FDA recognized nicotinamide riboside, which has pushed the stock back onto investors’ watchlists. See our latest analysis for Niagen Bioscience. Despite the recent excitement around new partner launches and clinical readouts, Niagen Bioscience’s share price has pulled back. The 30 day share price return shows a 24.11% decline and the 90 day...
NYSE:BRBR
NYSE:BRBRPersonal Products

BellRing Lawsuits Put Growth Story And Demand Assumptions Under Scrutiny

Multiple securities class action lawsuits have been filed against BellRing Brands (NYSE:BRBR), alleging the company misled investors about the drivers of its sales growth. Plaintiffs claim BellRing tied strong sales to sustainable demand rather than customer inventory stockpiling and did not fully disclose weakening demand and rising competition. The lawsuits, which also name certain executives, raise questions about BellRing's disclosures and could affect investor confidence and corporate...
NYSE:MGM
NYSE:MGMHospitality

Is MGM Resorts International (MGM) Pricing Look Interesting After Recent Share Price Moves

If you are wondering whether MGM Resorts International is priced fairly or offering value right now, you will want to look closely at how its current share price lines up with different valuation checks. The stock recently closed at US$36.28, with returns of 8.8% over the past 7 days, 1.5% over 30 days, a slight return of negative 0.6% year to date, 5.2% over 1 year, negative 17.7% over 3 years, and 2.8% over 5 years. This set of figures gives a mixed picture of recent and longer term...
NYSE:PWR
NYSE:PWRConstruction

Assessing Quanta Services (PWR) Valuation After Strong Growth And Data Center Power Optimism

Recent gains in Quanta Services (PWR) have drawn attention as investors weigh the company’s revenue and earnings growth, sizeable contract backlog, and upcoming February 19 earnings report against rising interest in data center power infrastructure. See our latest analysis for Quanta Services. The recent 1 month share price return of 9.01% and 1 day move of 2.83%, taking Quanta Services to US$477.72, sit alongside a 1 year total shareholder return of 53.74% and a very large 5 year total...
NasdaqGS:MDLZ
NasdaqGS:MDLZFood

Mondelez Expands Luca Zaramella’s Role As Investors Weigh Execution Risks

Mondelez International (NasdaqGS:MDLZ) has appointed longtime CFO Luca Zaramella as Chief Operating Officer. Zaramella will oversee commercial operations, sales, marketing, and supply chain while the company searches for a new CFO. He will temporarily hold both the COO and CFO positions, concentrating executive authority over Mondelez's global operations. For investors watching Mondelez International at a share price of $60.31, this leadership change follows mixed medium term returns. The...
NYSE:WEC
NYSE:WECIntegrated Utilities

A Look At WEC Energy Group (WEC) Valuation After Earnings Beat And Illinois Settlement

Why WEC Energy Group Is Back in Focus WEC Energy Group (WEC) landed on investor radars after fourth quarter results topped earnings and revenue forecasts, paired with reaffirmed 2026 guidance and a proposed settlement that clears key Illinois regulatory issues. See our latest analysis for WEC Energy Group. After the earnings beat, reaffirmed 2026 guidance and the proposed Illinois settlement, the current US$111.94 share price sits against a 30 day share price return of 5.65% and a 1 year...
NYSE:TOL
NYSE:TOLConsumer Durables

Toll Brothers (TOL) Valuation Check After New Luxury Community Launches Across Key US Markets

Toll Brothers (TOL) has been busy, rolling out and planning new luxury communities across Florida, California, Nevada, Georgia, Pennsylvania, Michigan, New York, Texas, and more. This burst of development helps frame how investors might think about the stock today. See our latest analysis for Toll Brothers. The recent string of community launches across Florida, California, Nevada, Georgia, Pennsylvania, Michigan, New York, Texas, and New Jersey has come alongside a 30 day share price return...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

Is Viatris’ New Deal-Tested CLO a Turning Point in Its Transformation Strategy (VTRS)?

Viatris Inc. recently announced that veteran pharmaceutical lawyer Matthew J. Maletta will become Chief Legal Officer on February 9, 2026, succeeding long-serving CLO Brian Roman, who will stay on as an advisor until April 1, 2026 to support the handover. Maletta’s background in managing complex transactions and legal teams across both generic and branded drug companies introduces a new legal leadership profile for Viatris as it continues its operational transformation. We’ll now examine how...
NasdaqGS:TMC
NasdaqGS:TMCMetals and Mining

Potential US Support Puts TMC Deep Sea Metals Story In Focus

U.S. executive actions are being discussed that could support TMC the metals through the Defense Production Act and related measures. These actions may include direct U.S. government equity investment in NasdaqGS:TMC to back its deep sea mining projects for critical battery metals. The potential support is tied to efforts to broaden supply chains for electric vehicle and renewable energy materials away from heavy reliance on China. NasdaqGS:TMC sits in a unique spot as it focuses on large...
NYSE:UNH
NYSE:UNHHealthcare

UnitedHealth Faces PBM Rule And Medicare Probe With Earnings In Focus

UnitedHealth Group (NYSE:UNH) is facing a proposed Department of Labor rule aimed at increasing transparency around Pharmacy Benefit Manager compensation. The company is also under Department of Justice investigation regarding its Medicare billing practices. These developments introduce regulatory, legal, and reputational risks that could affect parts of UnitedHealth's business model. UnitedHealth Group operates a broad health care business that includes insurance benefits and pharmacy...
NYSE:CNO
NYSE:CNOInsurance

A Look At CNO Financial Group (CNO) Valuation After Mixed Q4 Revenue And Earnings Results

Why CNO’s latest earnings matter for shareholders CNO Financial Group (CNO) reported fourth quarter and full year 2025 results with revenue slightly higher than a year earlier, while net income and earnings per share came in lower than the prior year. The update gave investors a fresh look at how this insurance provider is balancing growth in its top line with pressure on profitability, and it has become a focal point for how the stock is being reassessed after earnings. See our latest...
NYSE:HLI
NYSE:HLICapital Markets

A Look At Houlihan Lokey (HLI) Valuation After Earnings Beat And Growth Expansion Signals

Houlihan Lokey (HLI) is back in focus after quarterly results topped Wall Street forecasts, supported by active Corporate Finance work, heavier private equity deal flow, and fresh commentary around data monetization and European expansion. See our latest analysis for Houlihan Lokey. Recent news around earnings, European hiring and the completed share repurchase comes against a weaker price backdrop, with a 30 day share price return of 9.24% and a 1 year total shareholder return of 9.2%. The 3...
NasdaqGS:ZVRA
NasdaqGS:ZVRAPharmaceuticals

Zevra Therapeutics (ZVRA) Valuation Check As New MIPLYFFA Data And EMA Filing Draw Fresh Attention

Zevra Therapeutics (ZVRA) is back on investors’ radar after presenting new real world and clinical data on its approved Niemann Pick disease type C therapy MIPLYFFA at the 22nd Annual WORLDSymposium, alongside progress in Europe. See our latest analysis for Zevra Therapeutics. Zevra’s share price has been choppy recently, with a 1 day share price return of 6.49% and a 7 day share price return of 5.64% around the WORLDSymposium data. Its 1 year total shareholder return of 6.09% sits against a...
NYSE:PAGS
NYSE:PAGSDiversified Financial

Assessing PagSeguro Digital (NYSE:PAGS) Valuation After Recent Share Price Volatility

PagSeguro Digital (PAGS) is back on investors’ radar after recent share price volatility, with the stock closing at US$10.61 following mixed short term performance and stronger returns over the past year. See our latest analysis for PagSeguro Digital. That recent 1-day share price return of -2.30% and 7-day share price return of -11.58% comes after a steadier backdrop, with a 90-day share price return of 14.58% and 1-year total shareholder return of 45.88%. This suggests momentum has cooled...
NYSE:BLD
NYSE:BLDConsumer Durables

Is It Too Late To Consider Buying TopBuild (BLD) After Strong Multi‑Year Share Gains?

If you are wondering whether TopBuild's current share price still offers value, this article will walk through what the numbers are saying about the stock. The shares last closed at US$493.91, with returns of 2.9% over 7 days, 11.0% over 30 days, 14.5% year to date, 45.6% over 1 year and 151.1% over 3 years. These figures set the scene for a closer look at what investors are currently paying. Recent attention on TopBuild has been shaped by ongoing interest in the building products and...
NYSE:SRFM
NYSE:SRFMAirlines

Assessing Surf Air Mobility (SRFM) Valuation After New Hawaii eVTOL Integration Partnership News

Surf Air Mobility (SRFM) has drawn fresh attention after announcing a collaboration with Hawaii’s Department of Transportation and BETA Technologies on an eVTOL Integration Pilot Program under the White House’s Advanced Air Mobility National Strategy. See our latest analysis for Surf Air Mobility. Despite the eVTOL partnership headline, Surf Air Mobility’s recent trading has been weak, with a 30 day share price return of a 36.81% decline and a 1 year total shareholder return of a 53.92%...
NYSE:HRL
NYSE:HRLFood

What Hormel Foods (HRL)'s US$540 Million ESOP Shelf Registration Means For Shareholders

Hormel Foods Corporation recently filed a shelf registration for an ESOP-related offering of 21,951,785 shares of common stock, with an aggregate value of about US$540.23 million. This sizable ESOP-linked registration highlights Hormel’s ongoing use of equity-based employee ownership as part of its long-term capital and workforce incentives framework. With this large ESOP-related shelf registration as a focal point, we’ll now examine how the development shapes Hormel’s broader investment...
NasdaqGS:JD
NasdaqGS:JDMultiline Retail

Is JDcom (JD) Now A Contrarian Opportunity After Prolonged Share Price Weakness

With JD.com trading at around US$27.32 and investors weighing whether it is a value opportunity or a value trap, this article examines what the numbers may be indicating about the stock. The share price has faced pressure, with a 6.0% decline over 7 days, a 7.7% decline over 30 days, a 7.5% decline year to date, a 29.7% decline over the past year, a 47.1% decline over 3 years, and a 69.7% decline over 5 years. Recent headlines have focused on JD.com within broader discussions about Chinese...
NYSE:STC
NYSE:STCInsurance

A Look At Stewart Information Services (STC) Valuation After Strong Q4 Earnings Beat And Housing Recovery Hopes

Stewart Information Services (STC) just posted fourth quarter and full year 2025 results that topped analyst expectations on both revenue and adjusted earnings, with management pointing to better performance across all business lines. See our latest analysis for Stewart Information Services. The strong Q4 surprise and management’s comments about better conditions across all business lines appear to be feeding into sentiment, with a 1-day share price return of 2.92% and 7-day share price...
NasdaqGS:PLAB
NasdaqGS:PLABSemiconductor

Assessing Photronics (PLAB) Valuation After Recent Share Price Momentum And Conflicting Fair Value Signals

Why Photronics is on investors’ radar Photronics (PLAB) has drawn fresh attention after its recent share price moves, with the stock showing mixed short term returns but a strong performance profile over the past 3 months and 1 year. See our latest analysis for Photronics. With the share price at US$34.39, recent trading has been choppy in the very short term. However, a 90 day share price return of 58.41% alongside a 1 year total shareholder return of 50.24% suggests momentum has been...
NasdaqGS:FORM
NasdaqGS:FORMSemiconductor

FormFactor (FORM) Is Up 14.4% After Record Q4 Results And Upbeat HBM-Driven 2026 Guidance

FormFactor, Inc. has already reported its fourth-quarter and full-year 2025 results, delivering US$215.16 million in Q4 sales and higher quarterly net income and earnings per share versus the prior year, while full-year revenue of US$784.99 million came alongside lower annual net income and earnings per share. Management coupled these record quarterly and annual revenues with guidance for Q1 2026 that tops analyst expectations, pointing to strong demand in high-bandwidth memory, data...